NCT00052611 2018-03-29
Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia
Dana-Farber Cancer Institute
Phase 2 Completed
Dana-Farber Cancer Institute
Icahn School of Medicine at Mount Sinai
UConn Health
Fox Chase Cancer Center
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
Northwestern University